ArticleJAAD international2026
Development and validation of an Arabic vitiligo impact patient scale short form version.
Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There are few tools evaluating vitiligo patients' quality of life. A vitiligo impact patient scale short form (VIPs-SF) was developed in English. Objective: This study aims to develop a valid and reliable Arabic (AR) VIPs-SF version. Method: This cross-sectional study included 425 vitiligo patients. The VIPs-SF was translated into Arabic and was self-administered to patients according to their skin phototype. Patients also filled the AR-Dermatology Life Quality Index and the 9-question Patient Health Questionnaire for depression (PHQ-9). AR-VIPs-SF reliability, dimensional structure, and construct validity were assessed. Results: Both fair skin and dark skin AR-VIPs-SF had an excellent internal consistency (Cronbach's α: 0.92 and 0.91) and a good test-retest reliability (intraclass correlation coefficient: 0.82 and 0.81). Confirmatory factor analysis demonstrated acceptable fit based on comparative fit index/Tucker-Lewis index/standardized root mean square residual values, although χ Limitations: Absence of a discriminant validity assessment and comparison of AR-VIPs-SF to other vitiligo quality of life questionnaires. Responsiveness of AR-VIPs-SF to treatment should also be assessed. Conclusion: Arabic VIPs-SF proved valid and reliable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.